Answers are grounded in this paper and cite their sources.
We questioned whether the baseline status of low-density lipoprotein cholesterol (LDL-C), cholesterol synthesis and absorption, and the changes in these parameters determine the change in serum LDL-C under statin or ezetimibe treatment or under combination treatment.
No takes yet. Share an insight, caveat, or question.
Lütjohann et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: